1: Bayes M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2004 Sep;26(7):587-612. Review. PubMed PMID: 15538546.
2: Wilding G, King D, Tutsch K, Pomplun M, Feierabend C, Alberti D, Arzoomanian R. Phase I trial of the polyamine analog N1,N14-diethylhomospermine (DEHSPM) in patients with advanced solid tumors. Invest New Drugs. 2004 Apr;22(2):131-8. PubMed PMID: 14739661.
3: Bergeron RJ, Wiegand J, Fannin TL. Control of irritable bowel syndrome with polyamine analogs: a structure-activity study. Dig Dis Sci. 2001 Dec;46(12):2615-23. PubMed PMID: 11768250.
4: Bergeron RJ, Weimar WR, Müller R, Zimmerman CO, McCosar BH, Yao H, Smith RE. Effect of polyamine analogues on hypusine content in JURKAT T-cells. J Med Chem. 1998 Sep 24;41(20):3901-8. PubMed PMID: 9748365.
5: Bergeron RJ, Weimar WR, Wu Q, Feng Y, McManis JS. Polyamine analogue regulation of NMDA MK-801 binding: a structure-activity study. J Med Chem. 1996 Dec 20;39(26):5257-66. PubMed PMID: 8978854.
6: Bergeron RJ, Yao GW, Yao H, Weimar WR, Sninsky CA, Raisler B, Feng Y, Wu Q, Gao F. Metabolically programmed polyamine analogue antidiarrheals. J Med Chem. 1996 Jun 21;39(13):2461-71. PubMed PMID: 8691443.
7: Bergeron RJ, Weimar WR, Luchetta G, Sninsky CA, Wiegand J. Metabolism and pharmacokinetics of N1,N14-diethylhomospermine. Drug Metab Dispos. 1996 Mar;24(3):334-43. PubMed PMID: 8820425.
8: Bergeron RJ, Wiegand J, Sninsky CA, Katovich MJ. The impact of polyamine analogues on the blood pressure of normotensive and hypertensive rats. Clin Exp Hypertens. 1995 Nov;17(8):1197-217. PubMed PMID: 8563697.
9: Chang BK, Liang Y, Miller DW, Bergeron RJ, Porter CW, Wang G. Effects of diethyl spermine analogues in human bladder cancer cell lines in culture. J Urol. 1993 Oct;150(4):1293-7. PubMed PMID: 8371417.
10: Bergeron RJ, Hawthorne TR, Vinson JR, Beck DE Jr, Ingeno MJ. Role of the methylene backbone in the antiproliferative activity of polyamine analogues on L1210 cells. Cancer Res. 1989 Jun 1;49(11):2959-64. PubMed PMID: 2720656.